• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Bioelectronic Medicine

FDA grants breakthrough nod for Carthera’s SonoCloud-9

June 22, 2022 By Sean Whooley

Carthera announced today that it received FDA breakthrough device designation for its SonoCloud-9 system. Paris-based Carthera designed SonoCloud-9 for implantation in a skull window below the skin. Once in place, the device becomes invisible. When activated for a few minutes using a transdermal needle connected to an external control unit, it uses low-intensity pulsed ultrasound […]

Filed Under: Bioelectronic Medicine, Clinical Trials, Featured, Food & Drug Administration (FDA), Implants, Neurological, Neuromodulation/Neurostimulation, News Well, Oncology, Regulatory/Compliance, Ultrasound Tagged With: CarThera, FDA

MicroTransponder reports first commercial implantation of its stroke rehab neurostim system

May 20, 2022 By Chris Newmarker

MicroTransponder (Austin, Texas) recently announced the first commercial implantation of its Vivistim paired VNS system for chronic ischemic stroke rehabilitation. Dr. Charles Y. Liu, director of the University of Southern California Neurorestoration Center, and Dr. Jonathan J. Russin, director of the USC Neuro Revascularization Center, successfully placed the small Vivistim device under the skin of […]

Filed Under: Bioelectronic Medicine, Business/Financial News, Featured, Neuromodulation/Neurostimulation, News Well Tagged With: MicroTransponder Inc., Stroke

NeuroMetrix revenues rise in Q1

April 26, 2022 By Sean Whooley

NeuroMetrix (Nasdaq:NURO) shares dipped today on first-quarter results that saw losses despite year-over-year revenue growth. The Woburn, Massachusetts–based company posted losses of $958,562, or 14¢ per share, on sales of $2.3 million for the three months ended March 31, 2022, for a bottom-line slide deeper into the red on sales growth of 6.8%. NeuroMetrix’s biggest […]

Filed Under: Bioelectronic Medicine, Business/Financial News, Featured, Implants, MassDevice Earnings Roundup, Neurological, Neuromodulation/Neurostimulation, News Well, Pain Management, Wall Street Beat Tagged With: Neurometrix

Catheter delivery could enable better brain implants: Synchron’s neuroscience chief explains how

April 12, 2022 By Jim Hammerand

Synchron’s catheter delivery could make brain-computer interface technology simpler, safer and more accessible than the leading alternative: open-brain surgery. Officials at Synchron — developer of the catheter-delivered Stentrode brain-computer interface (BCI) implant — believe they’re the only BCI company tapping into blood vessels to capture signals from the brain. They say they’ve already enabled a […]

Filed Under: Bioelectronic Medicine, Catheters, Featured, Neurological, Neuromodulation/Neurostimulation, News Well Tagged With: brain stimulation, brain-computer interface, Synchron

Study produces ‘promising results’ for Carthera’s SonoCloud tech for mild Alzheimer’s symptoms

March 31, 2022 By Sean Whooley

Carthera announced positive results from a trial evaluating the safety and efficacy of the use of its SonoCloud technology. Results from the investigator-sponsored trial of SonoCloud in patients with mild Alzheimer’s Disease (AD) were published this week in the Alzheimer’s Research & Therapy Journal. Paris-based Carthera designed SonoCloud, an implantable 1 MHz ultrasound device, to be […]

Filed Under: Bioelectronic Medicine, Clinical Trials, Featured, Imaging, Implants, Neurological, Neuromodulation/Neurostimulation, News Well, Oncology, Ultrasound Tagged With: CarThera

Cala Health announces new chief commercial, financial officers amid leadership expansion

March 28, 2022 By Sean Whooley

Cala Health announced today that it has expanded its leadership team with a number of appointments, including new chief commercial and financial officers. New executives joining the company — which develops bioelectronic medicines to provide new therapies for chronic diseases — hold experience from major players in the medtech space, including iRhythm, Johnson & Johnson, […]

Filed Under: Bioelectronic Medicine, Business/Financial News, Digital Health, Featured, Health Technology, Neurological, Neuromodulation/Neurostimulation, Software / IT Tagged With: Cala Health, Personnel Moves

NeuroMetrix reports Q4 losses

January 28, 2022 By Sean Whooley

NeuroMetrix (NSDQ:NURO) today reported fourth-quarter results that included a bottom-line slide. The Woburn, Massachusetts–based neurostimulation technology developer posted losses of $1 million, or 15¢ per share, on sales of $1.8 million for the three months ended Dec. 31, 2021, for a bottom-line dip deeper into the red on sales growth of 0.6%. NeuroMetrix develops the […]

Filed Under: Bioelectronic Medicine, Business/Financial News, Featured, Implants, MassDevice Earnings Roundup, Neurological, Neuromodulation/Neurostimulation, News Well, Pain Management, Wall Street Beat Tagged With: Neurometrix

These medtech companies care a lot about research

January 19, 2022 By Chris Newmarker

They’re making glaucoma-treating stents, tumor-treating fields, coin-sized CGMs and more. Discover the medtech companies that spend the most on research as a percentage of revenue. The list comes from our annual Big 100 report, which examines the world’s 100 largest medical device companies and ranks them by revenue. (Check out our full Big 100 report […]

Filed Under: Bioelectronic Medicine, Business/Financial News, Cardiovascular, Diabetes, Featured, Neuromodulation/Neurostimulation, News Well, Oncology, Optical/Ophthalmic, Research & Development Tagged With: AtriCure Inc., Big 100, Dexcom, Glaukos, Inspire Medical Systems Inc., NovoCure

NIH launches $9.8M neuromodulation competition

January 18, 2022 By Sean Whooley

The National Institutes of Health (NIH) announced today that it launched the first phase of its Neuromod Prize competition. Neuromod Prize, a $9.8 million competition, aims to accelerate the development of neuromodulation therapies. NIH seeks scientists, engineers and clinicians to submit novel concepts and clinical development plans to demonstrate solutions for stimulating the peripheral nervous […]

Filed Under: Bioelectronic Medicine, Business/Financial News, Featured, Funding Roundup, Neurological, Neuromodulation/Neurostimulation, Pain Management, Research & Development Tagged With: National Institutes of Health (NIH), NIH

NeuroMetrix’s Quell wins FDA breakthrough designation to treat certain chemo side effects

January 18, 2022 By Sean Whooley

NeuroMetrix (NSDQ:NURO) announced today that it received FDA breakthrough device designation for its Quell technology. Woburn, Massachusetts-based NeuroMetrix’s Quell garnered the breakthrough nod for reducing moderate-to-severe symptoms of chemotherapy-induced peripheral neuropathy (CIPN) that have persisted for at least six months following the end of chemotherapy. Shares of NURO were up 36.6% at $6.72 per share […]

Filed Under: Bioelectronic Medicine, Clinical Trials, Featured, Food & Drug Administration (FDA), Neuromodulation/Neurostimulation, News Well, Oncology, Pain Management, Regulatory/Compliance Tagged With: FDA, Neurometrix

NeuroOne gains Nasdaq listing

May 26, 2021 By Sean Whooley

NeuroOne Medical Technologies (OTC:NMTC) announced that it was approved to uplist and begin trading on the Nasdaq market. Eden Prairie, Minn.-based NeuroOne expects trading to commence today at the open of the market, with the company trading under the “NMTC” ticker, according to a news release. The developer of surgical care options for patients suffering […]

Filed Under: Bioelectronic Medicine, Business/Financial News, Featured, Neurological, Neuromodulation/Neurostimulation, Pain Management, Wall Street Beat Tagged With: NASDAQ, neuroone

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 6
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS